UMIN ID: C000000155
Registered date:01/10/2005
randomized phase 2 study of Docetaxel+CBDCA versus weekly Paclitaxel+CBDCA
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | ovarian cancer |
| Date of first enrollment | 2002/01/01 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | docetaxel and carboplatin weekly paclitaxel and carboplatin |
Outcome(s)
| Primary Outcome | progression free survival |
|---|---|
| Secondary Outcome | quality of life ,safety |
Key inclusion & exclusion criteria
| Age minimum | 16years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Female |
| Include criteria | |
| Exclude criteria | pregnant or nursing woman |
Related Information
| Primary Sponsor | Osaka Medical College |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Kansai Clinical Oncology Group |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Kenichi Hosokawa |
| Address | Kajiicho465 Kamigyoku Kyoto city Japan Japan |
| Telephone | 075-251-5560 |
| hosokawa@koto.kpu-m.ac.jp | |
| Affiliation | Kyoto Prefectual University department of obstetrics and gynecology |
| scientific contact | |
| Name | Hiroyuki Yamaguchi |
| Address | Daigakucho2-7 Takatuki city Osaka Japan Japan |
| Telephone | 0726-83-1221 |
| Affiliation | osaka medical college department of obstetrics and gynecology |